- Home
- GNLX vs LFMDP Comparison
GNLX vs LFMDP Comparison
Compare GNLX & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- LFMDP
- Stock Information
- Founded
- GNLX 2001
- LFMDP N/A
- Country
- GNLX United States
- LFMDP United States
- Employees
- GNLX N/A
- LFMDP 232
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- LFMDP Medical/Nursing Services
- Sector
- GNLX Health Care
- LFMDP Health Care
- Exchange
- GNLX Nasdaq
- LFMDP Nasdaq
- Market Cap
- GNLX 103.6M
- LFMDP N/A
- IPO Year
- GNLX 2023
- LFMDP N/A
- Fundamental
- Price
- GNLX $2.27
- LFMDP $22.25
- Analyst Decision
- GNLX Strong Buy
- LFMDP
- Analyst Count
- GNLX 4
- LFMDP 0
- Target Price
- GNLX $18.25
- LFMDP N/A
- AVG Volume (30 Days)
- GNLX 141.5K
- LFMDP N/A
- Earning Date
- GNLX 11-14-2024
- LFMDP N/A
- Dividend Yield
- GNLX N/A
- LFMDP N/A
- EPS Growth
- GNLX N/A
- LFMDP N/A
- EPS
- GNLX N/A
- LFMDP N/A
- Revenue
- GNLX $8,000.00
- LFMDP N/A
- Revenue This Year
- GNLX N/A
- LFMDP N/A
- Revenue Next Year
- GNLX N/A
- LFMDP N/A
- P/E Ratio
- GNLX N/A
- LFMDP N/A
- Revenue Growth
- GNLX N/A
- LFMDP N/A
- 52 Week Low
- GNLX $1.60
- LFMDP N/A
- 52 Week High
- GNLX $16.60
- LFMDP N/A
- Technical
- Relative Strength Index (RSI)
- GNLX 38.68
- LFMDP 45.15
- Support Level
- GNLX $2.13
- LFMDP $22.12
- Resistance Level
- GNLX $2.80
- LFMDP $23.00
- Average True Range (ATR)
- GNLX 0.20
- LFMDP 0.16
- MACD
- GNLX -0.04
- LFMDP -0.07
- Stochastic Oscillator
- GNLX 14.21
- LFMDP 9.05
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About LFMDP LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.